Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, announced Wednesday the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the Company’s...
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.